BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 25, 2008
 |  BioCentury  |  Finance

EPS watch

EPS watch

EPS watch
Shire was the big winner last week as the earnings season comes to an end. The biotech tacked on over $1 billion in market cap after reporting EPS and revenues that beat the Street consensus. Mcap in $M
Company 4Q07 EPS est 4Q07 EPS actual Outcome Growth from 4Q06 2/22 cls Wk chg % chg Mcap chg 2/22 Mcap
Actelion (SWX:ATLN) NA CHF 0.71 NA 22% CHF51.85 -CHF1.15 -2% -$128.8 $5,720.2
In January, Actelion reported that 4Q07 revenues rose 42% to CHF370.9M ($327.4M), while full year revenues were up 39%...

Read the full 577 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury

Article Purchase

$150 USD
More Info >